Expression of the Giardia lamblia cyst wall protein 2 in Lactococcus lactis

Microbiology

Volumn 152, Issue 7, 2006, Pages 1981-1990

  Lee, Peter ^a   Faubert, Gaétan M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYST WALL PROTEIN 2; IMMUNOGLOBULIN A ANTIBODY; NISIN; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL SURFACE; CELL VIABILITY; CELLULAR DISTRIBUTION; COLONY FORMING UNIT; CONTROLLED STUDY; ELECTROPORATION; GIARDIA LAMBLIA; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON;

ANIMALS; BASE SEQUENCE; GIARDIA LAMBLIA; IMMUNITY, MUCOSAL; LACTOCOCCUS LACTIS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS;

GIARDIA; GIARDIA INTESTINALIS; LACTOCOCCUS; LACTOCOCCUS LACTIS; MURINAE;

EID: 33746068293     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.28877-0     Document Type: Article

References (59)

1. Bermudez-Humaran, L. G., Langella, P., Miyoshi, A., Gruss, A., Guerra, R. T., Montes de Oca-Luna, R. & Le Loir, Y. (2002). Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl Environ Microbiol 68, 917-922.
2. Bermudez-Humaran, L. G., Cortes-Perez, N. G., Le Loir, Y., Gruss, A., Rodriguez-Padilla, C., Saucedo-Cardenas, O., Langella, P. & Montes de Oca-Luna, R. (2003). Fusion to a carrier protein and a synthetic propeptide enhances E7 HPV-16 production and secretion in Lactococcus lactis. Biotechnol Prog 19, 1101-1104.
3. Bermudez-Humaran, L. G., Cortes-Perez, N. G., Le Loir, Y., Alcocer-Gonzalez, J. M., Tamez-Guerra, R. S., de Oca-Luna, R. M. & Langella, P. (2004). An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J Med Microbiol 53, 427-433.
4. Bernasconi, E., Germond, J. E., Delley, M., Fritsche, R. & Corthesy, B. (2002). Lactobacillus bulgaricus proteinase expressed in Lactococcus lactis is a powerful carrier for cell wall-associated and secreted bovine beta-lactoglobulin fusion proteins. Appl Environ Microbiol 68, 2917-2923.
5. Campbell, J. D. & Faubert, G. M. (1994a). Recognition of Giardia lamblia cyst-specific antigens by monoclonal antibodies. Parasite Immunol 16, 211-219.
6. Campbell, J. D. & Faubert, G. M. (1994b). Comparative studies on Giardia lamblia encystation in vitro and in vivo. J Parasitol 80, 36-44.
7. Carr, F. J., Chill, D. & Maida, N. (2002). The lactic acid bacteria: a literature survey. Crit Rev Microbiol 28, 281-370.
8. Cortes-Perez, N. G., Bermudez-Humaran, L. G., Le Loir, Y., Rodriguez-Padilla, C., Gruss, A., Saucedo-Cardenas, O., Langella, P. & Montes de Oca-Luna, R. (2003). Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol Lett 229, 37-42.
9. Cortes-Perez, N. G., Azevedo, V., Alcocer-Gonzalez, J. M., Rodriguez Padilla, C., Tamez-Guerra, R. S., Corthier, G., Gruss, A., Langella, P. & Bermudez-Humaran, L. G. (2005). Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli. J Drug Target 13, 89-98.
10. Daniels, C. W. & Belosevic, M. (1994). Serum antibody responses by male and female C57Bl/6 mice infected with Giardia muris. Clin Exp Immunol 97, 424-429.
11. de Ruyter, P. G., Kuipers, O. P. & de Vos, W. M. (1996). Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol 62, 3662-3667.
12. de Vos, W. M. (1999). Gene expression systems for lactic acid bacteria. Curr Opin Microbiol 2, 289-295.
13. Dieye, Y., Usai, S., Clier, F., Gruss, A. & Piard, J. C. (2001). Design of a protein-targeting system for lactic acid bacteria. J Bacteriol 183, 4157-4166.
14. Eckmann, L. (2003). Mucosal defences against Giardia. Parasite Immunol 25, 259-270.
15. Enouf, V., Langella, P., Commissaire, J., Cohen, J. & Corthier, G. (2001). Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. Appl Environ Microbiol 67, 1423-1428.
16. Erlandsen, S. L., Bemrick, W. J., Schupp, D. E., Shields, J. M., Jarroll, E. L., Sauch, J. F. & Pawley, J. B. (1990). High resolution immunogold localization of Giardia cyst wall antigens using field emission SEM with secondary and backscatter electron imaging. J Histochem Cytochem 38, 625-632.
17. Faubert, G. M., Lee, P. & Abdul-Wahid, A. (2002). Giardia duodenalis. In Infections of the Gastrointestinal Tract, pp. 978-1006. Edited by M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg & R. L. Guerrant. New York: LWW Publishing.
18. Frees, D., Varmanen, P. & Ingmer, H. (2001). Inactivation of a gene that is highly conserved in Gram-positive bacteria stimulates degradation of non-native proteins and concomitantly increases stress tolerance in Lactococcus lactis. Mol Microbiol 41, 93-103.
19. Geller, B. L., Wade, N., Gilberts, T. D., Hruby, D. E., Johanson, R. & Topisirovic, L. (2001). Surface expression of the conserved C repeat region of streptococcal M6 protein within the Pip bacteriophage receptor of Lactococcus lactis. Appl Environ Microbiol 67, 5370-5376.
20. Gibson, T. J. (1984). PhD thesis, University of Cambridge.
21. Gilbert, C., Robinson, K., Le Page, R. W. & Wells, J. M. (2000). Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis. Infect Immun 68, 3251-3260.
22. Heyworth, M. F. (1986). Antibody response to Giardia muris trophozoites in mouse intestine. Infect Immun 52, 568-571.
23. Heyworth, M. F. (1992). Immunology of Giardia and Cryptosporidium infections. J Infect Dis 166, 465-472.
24. Heyworth, M. F., Carlson, J. R., Ermak, T. H. (1987). Clearance of Giardia muris infection requires helper/inducer T lymphocytes. J Exp Med 165, 1743-1748.
25. Hlavsa, M. C., Watson, J. C. & Beach, M. J. (2005). Giardiasis surveillance - United States, 1998-2002. Morbid Mortal Wkly Rep Surveill Summ 54, 9-16.
26. Holo, H. & Nes, I. F. (1995). Transformation of Lactococcus by electroporation. Methods Mol Biol 47, 195-199.
27. Kok, J., van der Vossen, J. M. & Venema, G. (1984). Construction of plasmid cloning vectors for lactic streptococci which also replicate in Bacillus subtilis and Escherichia coli. Appl Environ Microbiol 48, 726-731.
28. Langella, P., Le Loir, Y., Ehrlich, S. D. & Gruss, A. (1993). Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis. J Bacteriol 175, 5806-5813.
29. Langford, T. D., Housley, M. P., Boes, M., Chen, J., Kagnoff, M. F., Gillin, F. D. & Eckmann, L. (2002). Central importance of immunoglobulin A in host defense against Giardia spp. Infect Immun 70, 11-18.
30. Larocque, R., Nakagaki, K., Lee, P., Abdul-Wahid, A. & Faubert, G. M. (2003). Oral immunization of BALB/c mice with Giardia duodenalis recombinant cyst wall protein inhibits shedding of cysts. Infect Immun 71, 5662-5669.
31. Le Loir, Y., Gruss, A., Ehrlich, S. D. & Langella, P. (1994). Direct screening of recombinants in gram-positive bacteria using the secreted staphylococcal nuclease as a reporter. J Bacteriol 176, 5135-5139.
32. Le Loir, Y., Gruss, A., Ehrlich, S. D. & Langella, P. (1998). A nine-residue synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis. J Bacteriol 180, 1895-1903.
33. Le Loir, Y., Nouaille, S., Commissaire, J., Bretigny, L., Gruss, A. & Langella, P. (2001). Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis. Appl Environ Microbiol 67, 4119-4127.
34. Lindholm, A., Smeds, A. & Palva, A. (2004). Receptor binding domain of Escherichia coli F18 fimbrial adhesin FedF can be both efficiently secreted and surface displayed in a functional form in Lactococcus lactis. Appl Environ Microbiol 70, 2061-2071.
35. Lujan, H. D., Mowatt, M. R., Conrad, J. T., Bowers, B. & Nash, T. E. (1995). Identification of a novel Giardia lamblia cyst wall protein with leucine-rich repeats. Implications for secretory granule formation and protein assembly into the cyst wall. J Biol Chem 270, 29307-29313.
36. Medaglini, D., Ciabattini, A., Spinosa, M. R., Maggi, T., Marcotte, H., Oggioni, M. R. & Pozzi, G. (2001). Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 19, 1931-1939.
37. Miyoshi, A., Poquet, I., Azevedo, V. & 7 other authors (2002). Controlled production of stable heterologous proteins in Lactococcus lactis. Appl Environ Microbiol 68, 3141-3146.
38. Nash, T. E., Herrington, D. A., Losonsky, G. A. & Levine, M. M. (1987). Experimental human infections with Giardia lamblia. J Infect Dis 156, 974-984.
39. Nilsson, D., Lauridsen, A. A., Tomoyasu, T. & Ogura, T. (1994). A Lactococcus lactis gene encodes a membrane protein with putative ATPase activity that is homologous to the essential Escherichia coli ftsH gene product. Microbiology 140, 2601-2610.
40. Norton, P. M., Brown, H. W. & Le Page, R. W. (1994). The immune response to Lactococcus lactis: implications for its use as a vaccine delivery vehicle. FEMS Microbiol Lett 120, 249-256.
41. Norton, P. M., Brown, H. W., Wells, J. M., Macpherson, A. M., Wilson, P. W. & Le Page, R. W. (1996). Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis. FEMS Immunol Med Microbiol 14, 167-177.
42. Norton, P. M., Wells, J. M., Brown, H. W., Macpherson, A. M. & Le Page, R. W. (1997). Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C. Vaccine 15, 616-619.
43. Nouaille, S., Ribeiro, L. A., Miyoshi, A., Pontes, D., Le Loir, Y., Oliveira, S. C., Langella, P. & Azevedo, V. (2003). Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res 2, 102-111.
44. Piard, J. C., Hautefort, I., Fischetti, V. A., Ehrlich, S. D., Fons, M. & Gruss, A. (1997a). Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J Bacteriol 179, 3068-3072.
45. Piard, J. C., Jimenez-Diaz, R., Fischetti, V. A., Ehrlich, S. D. & Gruss, A. (1997b). The M6 protein of Streptococcus pyogenes and its potential as a tool to anchor biologically active molecules at the surface of lactic acid bacteria. Adv Exp Med Biol 418, 545-550.
46. Pontes, D. S., Dorella, F. A., Ribeiro, L. A., Miyoshi, A., Le Loir, Y., Gruss, A., Oliveira, S. C., Langella, P. & Azevedo, V. (2003). Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen. J Drug Target 11, 489-493.
47. Poquet, I., Saint, V., Seznec, E., Simoes, N., Bolotin, A. & Gruss, A. (2000). HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing. Mol Microbiol 35, 1042-1051.
48. Ribeiro, L. A., Azevedo, V., Le Loir, Y., Oliveira, S. C., Dieye, Y., Piard, J. C., Gruss, A. & Langella, P. (2002). Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl Environ Microbiol 68, 910-916.
49. Robinson, K., Chamberlain, L. M., Schofield, K. M., Wells, J. M. & Le Page, R. W. (1997). Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 15, 653-657.
50. Robinson, K., Chamberlain, L. M., Lopez, M. C., Rush, C. M., Marcotte, H., Le Page, R. W. & Wells, J. M. (2004). Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun 72, 2753-2761.
51. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning. a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
52. Snider, D. P. & Underdown, B. J. (1986). Quantitative and temporal analyses of murine antibody response in serum and gut secretions to infection with Giardia muris. Infect Immun 52, 271-278.
53. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W. & Remaut, E. (2000). Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352-1355.
54. Terzaghi, B. E. & Sandine, W. E. (1975). Improved medium for lactic streptococci and their bacteriophages. Appl Environ Microbiol 29, 807-813.
55. Theisen, M., Soe, S., Brunstedt, K., Follmann, F., Bredmose, L., Israelsen, H., Madsen, S. M. & Druilhe, P. (2004). A Plasmodium falciparum GLURPMSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies. Vaccine 22, 1188-1198.
56. Vitini, E., Alvarez, S., Medina, M., Medici, M., de Budeguer, M. V. & Perdigon, G. (2000). Gut mucosal immunostimulation by lactic acid bacteria. Biocell 24, 223-232.
57. Wells, J. M., Wilson, P. W., Norton, P. M., Gasson, M. J. & Le Page, R. W. (1993). Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol 8, 1155-1162.
58. Wells, J. M., Robinson, K., Chamberlain, L. M., Schofield, K. M. & Le Page, R. W. (1996). Lactic acid bacteria as vaccine delivery vehicles. Antonie van Leeuwenhoek 70, 317-330.
59. Wu, H. Y. & Russell, M. W. (1993). Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 61, 314-322.